Restatement and Summary of Significant Accounting Policies - Additional Information (Details) - USD ($) $ in Thousands		1 Months Ended	3 Months Ended					6 Months Ended
	May 31, 2021	Feb. 28, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Accounting Policies [Line Items]
Net loss				$ (14,366)	$ (11,911)	$ (11,039)	$ (7,802)	$ (26,277)	$ (18,841)
Future milestone payments receivable	$ 135,000
Development milestone achieved								5,000
Collaboration revenue				525				993
Restricted cash				1,400				1,400		$ 300
Clinical Supply Agreement
Accounting Policies [Line Items]
Upfront payment received	$ 12,000
Milestone Achievements
Accounting Policies [Line Items]
Collaboration revenue		$ 5,000		100		0		400	0
Performance Obligations
Accounting Policies [Line Items]
Collaboration revenue				400		$ 0		600	$ 0
Performance Obligations | Subsequent Event
Accounting Policies [Line Items]
Collaboration revenue			$ 5,000
Revision of Prior Period, Error Correction, Adjustment
Accounting Policies [Line Items]
Net loss				100				4,800
Previously Reported
Accounting Policies [Line Items]
Net loss				(14,484)				(21,496)
Collaboration revenue				$ 407				$ 5,774
Previously Reported | Clinical Supply Agreement
Accounting Policies [Line Items]
Development milestone achieved					5,000
Previously Reported | Milestone Achievements
Accounting Policies [Line Items]
Collaboration revenue					$ 5,000
Pre Funded Warrants
Accounting Policies [Line Items]
Issuance of pre-funded warrants to purchase shares of common stock								5,000,000